Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hypercalcemia.Abeloff's clinical oncology. 4th edition. Churchill Livingston, Philadelphia2004
- Clinical practice. Hypercalcemia associated with cancer.N Engl J Med. 2005; 352: 373-379
- Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.J Clin Endocrinol Metab. 2003; 88: 1603-1609
- Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone.N Engl J Med. 1990; 323: 1324-1328
- Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas.Blood. 1993; 82: 1383-1394
- Hypercalcemia associated with malignancy.in: Favus M.J Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th edition. American Society for Bone and Mineral Research, Washington, DC2006: 195-199
- Mechanisms of bone lesions in multiple myeloma and lymphoma.Cancer. 1997; 80: 1557-1563
- Hypercalcemia in malignant and inflammatory diseases.Endocrinol Metab Clin North Am. 2002; 31: 141-158
- Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.Postgrad Med J. 1995; 71: 28-31
- Hypercalcemia of malignancy.Semin Nephrol. 2004; 24: 48-54
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.J Clin Oncol. 2001; 19: 558-567
- Oncologic emergencies: diagnosis and treatment.Mayo Clin Proc. 2006; 81: 835-848
- Hyponatremia.N Engl J Med. 2000; 342: 1581-1589
- Clinical practice. The syndrome of inappropriate antidiuresis.N Engl J Med. 2007; 356: 2064-2072
- Water intoxication following moderate-dose intravenous cyclophosphamide.Arch Intern Med. 1985; 145: 548-549
- Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone.N Engl J Med. 1979; 301: 528-530
- Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.JAMA. 1999; 281: 2299-2304
- Myelinolysis after correction of hyponatremia.Ann Intern Med. 1997; 126: 57-62
- Hyponatremia treatment guidelines 2007: expert panel recommendations.Am J Med. 2007; 120: S1-21
- Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia.Clin Nephrol. 1999; 51: 383-386
- Iatrogenic superior vena cava syndrome. A new entity.Cancer. 1984; 54: 376-378
- Thromboembolic disease involving the superior vena cava and brachiocephalic veins.Chest. 2003; 123: 809-812
- Approach to the patient who presents with superior vena cava obstruction.Chest. 1993; 103: 394S-397S
- Clinical practice. Superior vena cava syndrome with malignant causes.N Engl J Med. 2007; 356: 1862-1869
- Prognostic factors in patients with small cell lung carcinoma.Med Oncol. 2009; ([Epub ahead of print])
- Superior vena cava syndrome in small-cell lung cancer.Arch Intern Med. 1993; 153: 384-387
- Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.Thorax. 2009; 64: 174-178
- Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.AJR Am J Roentgenol. 2001; 177: 585-593
- Benign superior vena cava syndrome: stenting is now the first line of treatment.J Vasc Surg. 2008; 47: 372-380
- Superior vena cava syndrome: a contemporary review of a historic disease.Cardiol Rev. 2009; 17: 16-23
- Malignant effusive disease of the pleura and pericardium.Chest. 1997; 112: 291S-295S
- Malignancies involving the pericardium.Semin Thorac Cardiovasc Surg. 2000; 12: 119-129
- Acute cardiac tamponade.N Engl J Med. 2003; 349: 684-690
- Cardiac tamponade: hemodynamic observations in man.Circulation. 1978; 58: 265-272
- Pericardial and cardiac pressure.Circulation. 1988; 77: 1-5
- Pulsus paradoxus in cardiac tamponade: a pathophysiologic continuum.Clin Cardiol. 2003; 26: 215-217
- Diagnosis and management of cardiac tamponade in the era of echocardiography.Clin Cardiol. 1999; 22: 446-452
- Management of pericardial effusion: safety over novelty.Am J Cardiol. 1999; 83: 640
- Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade?.Am J Med. 1998; 105: 106-109
- Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trial.J Thorac Oncol. 2007; 2: 65-68
- Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.Br J Cancer. 2000; 83: 858-862
- Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.Jpn J Clin Oncol. 2005; 35: 57-60
- A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811).Br J Cancer. 2009; 100: 464-469
- Treatment of malignant pericardial effusion.JAMA. 1994; 272: 59-64
- Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage.Ann Thorac Surg. 1999; 67: 437-440
- Video-assisted thoracoscopic pericardial window for diagnosis and management of pericardial effusions.Ann Thorac Surg. 2005; 80: 607-610
- Rasburicase: a potent uricolytic agent.Expert Opin Pharmacother. 2002; 3: 433-442
- Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma.J Clin Oncol. 2001; 19: 697-704
- Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.Leukemia. 2005; 19: 34-38
- Recombinant urate oxidase (rasburicase) in the prophylaxis and treatment of tumor lysis syndrome.Contrib Nephrol. 2005; 147: 69-79
- Tumour lysis syndrome: new therapeutic strategies and classification.Br J Haematol. 2004; 127: 3-11
- Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.J Clin Oncol. 2008; 26: 2767-2778
- Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.J Clin Oncol. 2003; 21: 4402-4406
- Spinal cord compression in patients with advanced metastatic cancer: “all I care about is walking and living my life”.JAMA. 2008; 299: 937-946
- Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.Ann Neurol. 1978; 3: 40-51
- Metastatic epidural spinal cord compression.Lancet Neurol. 2008; 7: 459-466
- Clinical approach to metastatic epidural spinal cord compression.Hematol Oncol Clin North Am. 2006; 20: 1297-1305
- Experimental spinal cord compression by epidural neoplasms.Neurology. 1977; 27: 422-429
- Circulatory disturbance of the spinal cord with the epidural neoplasm in rats.J Neurosurg. 1985; 63: 260-265
- Spinal cord compression.Neurol Clin. 2003; 21: 67-86
- What can the history and physical examination tell us about low back pain?.JAMA. 1992; 268: 760-765
- The Barthel index in assessing the response to palliative radiotherapy in malignant spinal cord compression: a prospective audit.Clin Oncol. 1995; 7: 82-86
- Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of the vertebrae.Magn Reson Imaging. 1988; 6: 547-556
- High incidence of serious side effects of high dose dexamethasone treatment in patients with epidural spinal cord compression.J Neurooncol. 1992; 12: 141-144
- Effect of high dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial.Eur J Cancer. 1994; 30A: 22-27
- Initial bolus of conventional versus high dose dexamethasone in metastatic spinal cord compression.Neurology. 1989; 39: 1255-1257
- Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.Int J Radiat Oncol Biol Phys. 2007; 67: 525-531
- The Princess Margaret Hospital experience of malignant spinal cord compression [abstract].Proc Am Soc Clin Oncol. 2003; 22: 119
- Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.Lancet. 2005; 366: 643-648
- The pathogenesis and treatment of brain metastases: a comprehensive review.Crit Rev Oncol Hematol. 2004; 55: 199-215
- Current therapeutic approaches in patients with brain metastases.Curr Treat Options Oncol. 2006; 7: 479-489
- Increased intracranial pressure.Clin J Oncol Nurs. 2008; 12: 37-41
- Surgical and radiosurgical management of brain metastases.Surg Clin North Am. 2005; 85: 329-345
- Seizure prophylaxis in patients with brain tumors: a meta-analysis.Mayo Clin Proc. 2004; 79: 1489-1494
- Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.Clin J Oncol Nurs. 2007; 11: 87-95
- Hyperviscosity syndrome in dysproteinemias.Am J Med Sci. 1972; 264: 123-126
- Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenström's macroglobulinemia.Invest Ophthalmol Vis Sci. 2008; 49: 1157-1160
- Lymphoplasmacytic lymphoma-Waldenström's macroglobulinemia.Crit Rev Oncol Hematol. 2008; 67: 172-185
- Hyperviscosity-related retinopathy in Waldenström macroglobulinemia.Arch Ophthalmol. 2006; 124: 1601-1606
- Central retinal occlusion due to hyperviscosity syndrome.J Emerg Med. 2000; 18: 23-26
- Correction of hyperviscosity by apheresis.Semin Thromb Hemost. 2003; 29: 535-542
- Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.Cancer. 2008; 113: 522-529
- Acute leukemia with a very high leukocyte count: confronting a medical emergency.Cleve Clin J Med. 2004; 71: 633-637
- Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management.Leuk Lymphoma. 2000; 39: 1-18
- Leukocytoreduction for acute leukemia.Ther Apher. 2002; 6: 15-23
- Interventional bronchoscopy: 5-year experience at the Academic Hospital of the Vrije Universiteit Brussel (AZ-VUB).Acta Clin Belg. 1997; 52: 371-380
- Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.Chest. 2006; 130: 1803-1807
- Airway stenting for malignant and benign tracheobronchial stenosis.Ann Thorac Surg. 2003; 76 ([discussion: 173–4]): 167-172
- Airway stents.Ann Thorac Surg. 2008; 85: S792-S796
- Airway stenting.Chest Surg Clin N Am. 2003; 13: 211-229
- Management of malignant esophagotracheal fistulas with airway stenting and double stenting.Chest. 1996; 110: 1155-1160
- Seven-year experience with the Dumon prosthesis.J Bronchol. 1996; 31: 6-10
- Outcomes of tracheobronchial stents in patients with malignant airway disease.Ann Thorac Surg. 2005; 80 ([discussion: 437–8]): 434-437
- Tracheobronchial stenting and central airway replacement.Curr Opin Pulm Med. 2007; 13: 278-283
- Endoscopic treatment of malignant airway obstructions in 2,008 patients.Chest. 1996; 110: 1536-1542
- Endobronchial palliation using Nd:YAG laser is associated with improved survival when combined with multimodal adjuvant treatments.J Thorac Oncol. 2007; 2: 59-64
- Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study.Lung Cancer. 2000; 27: 169-175
- Endobronchial radiation therapy with or without neodymium yttrium aluminum garnet laser resection for managing malignant airway obstruction.Cancer. 1994; 73: 2583-2588
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
